ADARx Pharmaceuticals, Inc. (NASDAQ:ADRX) IPO
IPO
Priced at US$17.00 a share on Sep 24, 2026.
- Price
- US$17.00 a share
- Shares offered
- 26,250,000 shares of common stock
- Offering size
- US$446.3 million
- Underwriters' option
- Up to 3,937,500 more shares
- Listing
- ADRX on the Nasdaq Global Select Market
- Underwriters
- J.P. Morgan, Morgan Stanley, TD Cowen, UBS Investment Bank, LifeSci Capital · In the order on the cover
- Shares delivered
- On or about Sep 28, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 22, 2026 |
| Filed publicly | Sep 4, 2026 |
| Amended twice | Newest Sep 21, 2026 |
| Shares registered with an exchange | Sep 22, 2026 |
| Declared effective by the SEC | Sep 24, 2026 |
| Final prospectus, with the price | Sep 28, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 28, 2026 |
| EFFECT · Notice that a registration is effective | Sep 24, 2026 |
| S-1MEF · Registration of more shares for the same offering | Sep 24, 2026 |
| CERT · Exchange's certificate of listing | Sep 24, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 22, 2026 |
| S-1/A · Registration statement, amended | Sep 21, 2026 |
| S-1/A · Registration statement, amended | Sep 14, 2026 |
| S-1 · Registration statement | Sep 4, 2026 |
| DRS/A · Draft registration statement, amended | Jul 31, 2026 |
| DRS · Draft registration statement | Jun 22, 2026 |
From the cover of the final prospectus (424B4) filed Sep 28, 2026